SCHEMBL7107586

SCHEMBL7107586

CC(OC(C)S(N)(=O)=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.39
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA9 Q16790 3/20 0.37
CA12 O43570 2/20 0.37
CA7 P43166 2/20 0.37
TAAR1 Q96RJ0 2/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GMNN O75496 1/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
PMP22 Q01453 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FFAR2 O15552 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL198133 0.76 HCAR2 (0.45) HCAR2TAAR1LMNAKDM4EALDH1A1
SCHEMBL5892165 0.76 CA1 (0.44) HCAR2CA1CA2CA9CA12
SCHEMBL6272307 0.74 HCAR2 (0.46) HCAR2TAAR1LMNAKDM4EKMT2A
Ammonia Solution, Strong SCHEMBL27871924 0.74 HCAR2 (0.44) HCAR2TAAR1LMNAKDM4EALDH1A1
Hydrochloric Acid SCHEMBL28273439 0.74 ALDH1A1 (0.44) HCAR2TAAR1LMNAKDM4EALDH1A1
Phosphine SCHEMBL20897413 0.74 CYP2D6 (0.46) HCAR2TAAR1LMNAKDM4EALDH1A1
SCHEMBL1792962 0.73 PTGES2 (0.44) CA1CA2CA9CA12CA7
SCHEMBL18028786 0.73 PTGES2 (0.44) CA1CA2CA9CA12CA7
SCHEMBL18028833 0.73 PTGES2 (0.44) CA1CA2CA9CA12CA7
SCHEMBL28040936 0.72 CA1 (0.48) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345591-A1 PHARMACEUTICAL AEROSOL FORMULATION AstraZeneca AB (SE) 2003-09-24 EP disclosed
WO-2002049616-A1 PHARMACEUTICAL AEROSOL FORMULATION ASTRAZENECA AB (SE) 2002-06-27 WO disclosed